drugset
Drugs / GSK1360707
last change Oct 2009 re-read 3 minutes ago

GSK1360707

also known as 1-(3,4-dichlorophenyl)-6-(methoxymethyl)-3-azabicyclo[4.1.0]heptane (enantiomeric mix)

Small molecule

Investigated by
GlaxoSmithKline

Trials 1

today NCT01153802 · Ph 1
2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01153802 Apr → Oct 2009 depressive disorder GlaxoSmithKline Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as GSK1360707 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01153802 ↗
Known as 1-(3,4-dichlorophenyl)-6-(methoxymethyl)-3-azabicyclo[4.1.0]heptane (enantiomeric mix) ChEMBL registry synonym — accepted as the source's own label CHEMBL1173532 ↗
Action Inhibit “GSK1360707 is a potent re-uptake inhibitor” NCT01153802 ↗
Modality Small molecule — CHEMBL1173532 ↗
Route Oral “Single Oral Doses of GSK1360707” NCT01153802 ↗